Arcutis Biotherapeutics, Inc. earnings per share and revenue

ARQT earnings per share for the last quarter are -0.09 USD whereas the estimation was -0.26 USD which accounts for 64.77% surprise. Company revenue for the same period amounts to 71.36 M USD despite the estimated figure of 60.79 M USD. Estimated earnings per share for the next quarter are -0.20 USD, and revenue is expected to reach 64.54 M USD. Also watch annual changes over time to get a bigger picture of ARQT earnings per share and revenue dynamics.